Lindsay Rosenwald Accomplishments

Lindsay Rosenwald began his professional studies at Pennsylvania State University in 1973 after graduating from Abington High School. He excelled a business and was particularly fascinated with economics and finance. He was a member of Beta Gamma Sigma, the business school’s honors society. In 1977, he graduated with his Bachelors degree in Finance. Despite his aptitude and interest in business, Lindsay Rosenwald had always wanted to be a doctor.

In pursuit of his lifelong dream, Rosenwald entered Temple University’s School of Medicine. After graduating from Temple University in 1983, he began an internship at Abington Hospital before starting his own private practice. He worked as a physician in his practice for two and a half years. Though he enjoyed being a doctor, Rosenwald desired a career where he could combine his two loves – medicine and business.

Lindsay Rosenwald left his private practice in 1986 to head to Wall Street where he took on a position as a Physician / Analyst, a very unique position with only a few people doing it at the time. Despite the stereotype that doctors do not make good investors, Dr. Rosenwald excelled at this position. He worked here because he felt it was important to focus on investments in the healthcare industry. People admired him and respected his opinions and expertise. While he missed treating patients, he knew this was where he belonged. During this time, he also worked for D.H. Blair and Company, a private investment company, as the managing director of corporate finance. After a few years, he left D.H. Blair and Company to focus on a new project and company.

In 1991, Lindsay Rosenwald founded Paramount Biotech. Over time, he has expanded this company by starting new companies and gaining control of other biotech companies. It has created or financed over 40 companies – over 25 of which have been in the past three years. He builds these companies by focusing on the growth of both the corporate and biotechnology portions. Now, Paramount Capital is comprised of many companies. These companies include Paramount Biosciences, which creates and supports new biotechnology companies, Paramount Corporate Development, which works to build the Paramount Corporation as well as develop new drugs, and Paramount BioCapital, a broker-dealer which has raise over $950 billion in profit since it started. The companies that Rosenwald controls have licensed or acquired over 100 experimental stage medicines.

Perhaps one of Dr. Rosenwald’s greatest achievements is that he set the record for the quickest development of a drug. In only 30 months, Arsenic Trioxide was developed and approved by the FDA for the treatment of a deadly form of leukemia. This drug has been on the market worldwide for over a decade and has saved and extended thousands of lives.

Lindsay Rosenwald has been revolutionary with the companies he has created. In one of the greatest reverse mergers of all time, his company, Cougar Biotechnology, sold for over $1 billion to Johnson and Johnson, despite only having a single drug with phase 2 clinical data. He has also founded the first publicly traded stem cell company, gene therapy company, and cancer vaccine company. Under Rosenwald’s leadership, his companies have developed countless groundbreaking drugs, including Peramivir for H1N1 Influenza, Fanapt for schizophrenia, Savella for fibromyalgia, and Trisinox for acute leukemia. He is also responsible for the first successful anti-obesity drug developed in the United States market in 30 years.

One of the reasons that Rosenwald’s companies have been successful is that he hires PHDs, MDs, MBAs, and other experts to serve as his senior level professionals. These people bring a great amount of experience in both the medical and business arenas which helps make his companies stronger and more diverse. They strive to develop new medicines with great focus and efficiency. These companies are blazing the trail of new medicines and treatments that will change the practice of medicine. He has also created the Rosenwald Foundation which has donated millions of dollars to medical and science instruction to help build the future of medicine.
Dr. Lindsay Rosenwald is the world’s most prolific entrepreneur in the history of the biotechnology industry. People attribute the success of biotechnology on Wall Street in the last 30 years to him. His personal assets total greater than $600 million. In 2002, Rosenwald topped the list of Genetic Engineering News’ 100 Molecular Millionaires.

Lindsay Rosenwald has built his business by constantly looking towards the future and now is no exception. Dr. Rosenwald believes that there will continue to be rapid growth in the biotechnology industry over the next twenty years. At the rate it is developing, this growth will be exponential. According to Rosenwald, future medical breakthroughs will come through small biotech companies that are focused in on producing only a few products, rather than a giant biotech company that has many projects in work at once. Rosenwald believes that focus should now be placed on finding treatments for two of society’s biggest medical threats – heart disease and cancer.